Aragen News and Resources

Aragen, a Contract Research, Development and Manufacturing Organisation (CRDMO), has secured a $100 million investment from Quadria Capital, an Asia-focused private equity fund specialising in healthcare. The deal, which values Aragen at approximately $1.4 billion, includes a combination of fresh

Aragen, a Contract Research Development and Manufacturing Organisation (CRDMO) specialising in small molecules and biologics, has announced the operationalisation of the first phase of its biologics manufacturing facility in Bangalore, India. The $30 million facility has completed its inaugural small-scale